Our September sale is now live until 30th September 2021! Apply a 15% discount to your cart in Store using promotional code: EQLYSEP21

Cooper Cos Inc, The in Eyewear

December 2017

CooperVision (CVI), the vision care unit of The Cooper Cos Inc, has carved a niche for itself in specialty lenses. It has also increasingly been competing in the arena of silicone hydrogel daily disposables (DDs) since acquiring Sauflon in 2014. In future, CVI’s success will depend on its capacity to compete against larger players, like Johnson & Johnson, through building stronger brand recognition in DDs, keeping its status in specialty lenses, and increasing sales online and in emerging market

USD 570
Request More Information

Delivery

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

Overview:

Euromonitor International's report on Cooper Cos Inc, The delivers a detailed strategic analysis of the company's business, examining its performance in the Eyewear market and the global economy. Company and market share data provide a detailed look at the financial position of Cooper Cos Inc, The, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Cooper Cos Inc, The.

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Cooper Cos Inc, The provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Eyewear research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Scope of the Report

Scope

Strategic Evaluation

Key company facts
CVI’s business is largely concentrated in the US and Japan
Sales of daily disposable lenses have surged in recent years
A key brand of “specialty lenses”
SWOT: Cooper Cos Inc , The

Competitive Positioning

A highly concentrated market
CVI’s largest competitors are Valeant Pharmaceutical and Novartis
CVI’s sales performance in perspective

MARKET ASSESSMENT

DDs set to be the most dynamic category but FRPs remain dominant
Internet retailing is becoming a key channel for contact lenses

Geographic and Category Opportunities

US and Asia Pacific to drive sales of daily disposables
CVI is well placed to take advantage of the growth in FRPs
Opportunities present in specialty lenses
Material developments as an opportunity area
‘Smart lenses’: Looking beyond refractive corrections

Brand Strategy

Comprehensive multi-tier portfolio
Banking on the toric opportunity
Multifocal contact lenses remain hot area for investment
Embracing the digital eye fatigue opportunity with Biofinity Energys
Increasing practitioner focus

Operations

Investing in R&D and customer service to ECPs
CVI global operations

Recommendations

Add value and pursue emerging market opportunities

Report Definitions

Definitions

Appendix: Competitor Analytics

Competitor Analytics tool
Overview
Competitors
Market Overlap
Treemap
Overlap Matrices
Share:

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page